Navratil-Strawn J, Hartley S, MacLeod S, Lindsay A. The effect of a customized advocacy product on downstream medical expenditures and utilization. Telehealth and medicine today. 2021 Jan;6(2). doi: 10.30953/tmt.v6.250
DiTrapani J, Rockwood N, Jeon M. Explanatory IRT analysis using the SPIRT macro in SPSS. TQMP. 2018;14(2):81-98. doi: 10.20982/tqmp.14.2.p081
Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-utility analysis of treatments for advanced non-small cell lung cancer. Am J Pharm Benefits. 2015 Nov;7(6):271-9.
Lopes M, Chulikavit M, Parikh R, Stern L, Liu Z, Rogerio J. Budget impact of everolimus in treating metastatic renal cell carcinoma. Am J Pharm Benefits. 2012;4(Special Issue):sp41-8.